These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22713147)

  • 1. Blood pressure treatment target in patients with diabetes mellitus--current evidence.
    Barengo NC; Tuomilehto JO
    Ann Med; 2012 Jun; 44 Suppl 1():S36-42. PubMed ID: 22713147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
    Bangalore S; Kumar S; Lobach I; Messerli FH
    Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions.
    Black HR
    J Hypertens Suppl; 1999 Dec; 17(5):S49-54. PubMed ID: 10706327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we change the target blood pressure in diabetic patients?
    Shlomai G; Grossman E
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():1-7. PubMed ID: 23280860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valsartan in patients with arterial hypertension and type 2 diabetes mellitus. The lapaval study].
    Rodríguez Pérez JC; Novoa Novoa J; Caballero A; Anabitarte A; Plaza C; Palop L; Rodríguez Esparragón F
    Nefrologia; 2005; 25(5):500-8. PubMed ID: 16392299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes.
    Vepsäläinen T; Laakso M; Kantola I; Lehto S; Juutilainen A; Rönnemaa T
    J Intern Med; 2012 Dec; 272(6):611-9. PubMed ID: 22891848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control among Indians with hypertension: the I-Target survey.
    Hathial M
    J Indian Med Assoc; 2007 Jul; 105(7):401-2, 404, 410. PubMed ID: 18178998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM; Baguet JP; Siché JP; Benkritly A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hypertension in diabetic patients: outstanding issues.
    Camafort-Babkowski M; Barrios V; Coca A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):721-8. PubMed ID: 21714603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there new threshold and goals in the treatment of arterial hypertension?
    Segura J; Ruilope LM
    Eur J Clin Invest; 2012 Aug; 42(8):914-20. PubMed ID: 22404687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
    Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
    Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.